Tacrolimus Capsules


Indications and Reactions:

Role Indications Reactions
Primary
Lupus Nephritis 17.8%
Product Used For Unknown Indication 16.9%
Prophylaxis 16.0%
Renal Transplant 8.0%
Plasma Cell Myeloma 7.6%
Liver Transplant 6.9%
Rheumatoid Arthritis 2.7%
Hypertension 2.4%
Insomnia 2.4%
Myasthenia Gravis 2.4%
Colitis Ulcerative 2.2%
Skin Ulcer 2.0%
Stem Cell Transplant 1.8%
Systemic Lupus Erythematosus 1.8%
Constipation 1.6%
Hyperlipidaemia 1.6%
Immunosuppression 1.6%
Schizophrenia 1.6%
Bone Marrow Transplant 1.3%
Prophylaxis Against Graft Versus Host Disease 1.3%
Death 51.9%
Off Label Use 5.1%
Posterior Reversible Encephalopathy Syndrome 5.1%
Renal Disorder 5.1%
Pneumonia 3.8%
Schizophrenia 3.8%
Transplant Failure 3.8%
Urinary Tract Infection 3.8%
Upper Respiratory Tract Inflammation 2.5%
Ureteric Stenosis 2.5%
Angioimmunoblastic T-cell Lymphoma Recurrent 1.3%
Biliary Cirrhosis Primary 1.3%
Blood Creatinine Increased 1.3%
Blood Pressure Increased 1.3%
Cholecystitis 1.3%
Diarrhoea 1.3%
Drug Level Fluctuating 1.3%
Duodenal Ulcer 1.3%
General Physical Health Deterioration 1.3%
Glomerular Filtration Rate Decreased 1.3%
Secondary
Prophylaxis 19.9%
Lupus Nephritis 18.1%
Colitis Ulcerative 15.9%
Product Used For Unknown Indication 12.1%
Skin Ulcer 6.7%
Bone Marrow Transplant 3.2%
Graft Versus Host Disease 3.2%
Systemic Lupus Erythematosus 3.0%
Hyperlipidaemia 2.9%
Herpes Zoster 1.9%
Mixed Connective Tissue Disease 1.9%
Myasthenia Gravis 1.9%
Renal Transplant 1.6%
Insomnia 1.4%
Upper Respiratory Tract Inflammation 1.3%
Constipation 1.1%
Schizophrenia 1.1%
Arthralgia 1.0%
Asthma 1.0%
Calculus Ureteric 1.0%
Tremor 18.1%
Renal Disorder 10.8%
Urinary Tract Infection 10.8%
Liver Disorder 7.2%
Systemic Lupus Erythematosus 7.2%
Wrong Technique In Drug Usage Process 6.0%
Cholecystitis 4.8%
General Physical Health Deterioration 4.8%
No Adverse Event 4.8%
Muscular Weakness 3.6%
Schizophrenia 3.6%
Tinea Manuum 3.6%
Duodenal Ulcer 2.4%
Influenza 2.4%
Nephrolithiasis 2.4%
Upper Respiratory Tract Inflammation 2.4%
Angioimmunoblastic T-cell Lymphoma Recurrent 1.2%
Blood Pressure Increased 1.2%
Diarrhoea 1.2%
Drug Level Fluctuating 1.2%

Drug Data